Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

7.30USD
10:22am EDT
Price Change (% chg)

$0.23 (+3.25%)
Prev Close
$7.07
Open
$7.08
Day's High
$7.33
Day's Low
$7.07
Volume
306,634
Avg. Vol
6,479,873
52-wk High
$8.61
52-wk Low
$2.26

ACHN.O

Chart for ACHN.O

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the... (more)

Overall

Beta: 1.97
Market Cap (Mil.): $684.35
Shares Outstanding (Mil.): 96.80
Dividend: --
Yield (%): --

Financials

  ACHN.O Industry Sector
P/E (TTM): -- 103.84 36.07
EPS (TTM): -0.65 -- --
ROI: -37.94 -0.24 18.18
ROE: -37.97 -1.24 19.05
Search Stocks

US STOCKS-Wall St ends near flat; Dow hits record for 4th day

* Dow up 0.02 pct, S&P 500 down 0.02 pct, Nasdaq up 0.04 pct (Updates to close)

10 Jun 2014

US STOCKS-Wall St dips after string of recent Dow, S&P records

* Dow down 0.1 pct, S&P 500 down 0.1 pct, Nasdaq down 0.1 pct (Updates to late afternoon, changes byline)

10 Jun 2014

US STOCKS-Wall St dips, stays near record peaks; incentives scant

* Dow, S&P 500 and Nasdaq all fall 0.1 pct (Updates to midday trading)

10 Jun 2014

US STOCKS-Wall St recedes modestly from record levels

* Indexes down: Dow 0.2 pct S&P 500 0.3 pct, Nasdaq 0.3 pct (Updates to open)

10 Jun 2014

US STOCKS-Futures point to early drop from record levels

* Futures down: Dow 20 pts, S&P 4.4 pts, Nasdaq 8.25 pts (Updates prices, adds RadioShack)

10 Jun 2014

FDA lifts hold on Achillion's hepatitis C drug, shares jump

June 10 - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration allowed it to resume the development of one of its hepatitis C drugs, lifting a clinical hold that was imposed nearly a year ago.

10 Jun 2014

US STOCKS-Futures dip, S&P 500 comes off 4th straight record

NEW YORK, June 10 - U.S. stock index futures edged lower on Tuesday, as investors found few reasons to keep buying with the Dow and S&P 500 just off the latest in a string of records.

10 Jun 2014

Competitors

  Price Change
Pfizer Inc. (PFE.N) $30.16 +0.06
Johnson & Johnson (JNJ.N) $102.02 -0.09
Novartis AG (NOVN.VX) CHF80.15 +0.75
Merck & Co., Inc. (MRK.N) $58.79 +0.82
Roche Holding Ltd. (ROG.VX) CHF266.80 +1.30
Abbott Laboratories (ABT.N) $42.80 -0.13
AstraZeneca plc (AZN.L) 4,335.50p -25.50
GlaxoSmithKline plc (GSK.L) 1,425.50p +11.00
Bristol-Myers Squibb Co (BMY.N) $50.34 +0.54
Bristol-Myers Squibb Co (BMYMP.PK) $829.72 -58.28

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks